Alla studier
RekryteringOBSERVATIONELL

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

This study aims to understand more about Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) in people aged 12 and older. It's an observational study, which means participants won't receive a new treatment or medication. Instead, researchers will gather information about how these conditions affect daily life and health. This will involve regular visits over six months to check symptoms, take blood samples, measure vital signs, and possibly wear a device to track light exposure. Participants will also keep a daily diary of their symptoms. The goal is to collect important data that could help improve our understanding and care for people with EPP and XLP.

Överblick

Status
Rekrytering
Sponsor
Portal Therapeutics, Inc.
Inskrivningsmål
50
Starta
30 apr 2026
Beräknad slutförande
01 apr 2027

Vad handlar denna studie om?

This study focuses on two rare conditions called Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP). If you or someone you know has been diagnosed with one of these conditions, you might be familiar with the challenges they can bring, especially related to sun exposure. The main purpose of this research is to collect detailed information about how these conditions affect adults and teenagers in their everyday lives.

It's important to know that this isn't a study where you'll try a new medicine or treatment. Instead, it's an 'observational' study. This means the researchers will simply observe and record information about your condition as it is, without changing your current care. By carefully collecting these details from many people, scientists can gain a much clearer picture of EPP and XLP.

The information gathered will help doctors and researchers understand the conditions better, which could eventually lead to improved ways to diagnose, manage, and care for people living with EPP and XLP in the future. Your participation could make a real difference in advancing our knowledge.

Viktiga punkter

  • Study collects information on EPP/XLP in ages 12 and up.
  • It's an observational study; no new treatments are given.
  • Participation involves periodic visits and symptom diaries over 6 months.
  • Helps researchers understand EPP/XLP better, potentially improving future care.
  • Du kan dra dig ur studien när som helst.

Vem kan vara berättigad?

To join this study, you need to be at least 12 years old and have a confirmed diagnosis of EPP or XLP. This diagnosis might be based on genetic tests showing specific changes in your genes, or on blood tests that show high levels of a substance called PPIX, along with your symptoms and family history.

You should currently be experiencing symptoms of EPP or XLP. A key part of this is having a history of feeling a consistent, non-painful sensation within about 45 minutes of sun exposure, just before you experience more severe skin reactions. You also need to be willing to participate fully, which includes wearing a special device that measures light, keeping a daily diary of your symptoms, and covering certain areas of your skin when asked for specific tests.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Är du 12 år eller äldre?
  2. Do you have a confirmed diagnosis of EPP or XLP?
  3. Are you currently experiencing symptoms related to EPP/XLP?
  4. Do you have a history of feeling early, mild symptoms before sun-related skin reactions?
  5. Are you willing to wear a light-measuring device and keep a daily symptom diary?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part, the study will last for up to 6 months. After an initial screening, you'll have a first main visit (called Baseline Day 1). Over the next 24 weeks, you'll come back for follow-up visits every 4 weeks.

During these visits and at home, you'll be asked to do several things. This includes having standard checks like physical exams, measuring your blood pressure and heart rate (vital signs), and giving blood samples to check certain levels in your blood. You might also be asked to wear a device that measures the amount of light you're exposed to. A very important part of the study is keeping a daily diary to record your EPP/XLP-related symptoms. It's also possible you may need to keep certain skin areas covered before specific tests, as explained by the study team. You won't receive any new treatments as part of this study.

Potentiella risker och fördelar

Participating in this study might not directly benefit your health immediately, as it doesn't involve new treatments. However, the information gathered could significantly help future patients by improving our overall understanding of EPP and XLP. Potential risks are generally low, mainly involving the inconvenience of regular visits, blood draws which can cause minor bruising or discomfort, and the time commitment for daily diary entries. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Platser (19)

  • Massachusetts General Hospital
    Verifierat postnummer
    Boston, USA· Rekrytering
  • Mount Sinai School of Medicine
    Verifierat postnummer
    New York, USA· Rekrytering
  • Wake Forest University Baptist Health - Dept of Gastroenterology
    Verifierat postnummer
    Wake Forest, United States· Rekrytering
  • Temple University
    Verifierat postnummer
    Philadelphia, USA· Rekryterar inte ännu
  • University of Texas Health - Ertan Digestive Disease Center
    Verifierat postnummer
    Houston, USA· Rekrytering
  • UZ Leuven
    Verifierat postnummer
    Leuven, Belgien· Rekryterar inte ännu
  • University of Alberta Hospital
    Verifierat postnummer
    Edmonton, Kanada· Rekryterar inte ännu
  • Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre
    Verifierat postnummer
    Bordeaux, Frankrike· Rekryterar inte ännu
  • AP-HP Hopital Bichat - Claude Bernard
    Verifierat postnummer
    Paris, Frankrike· Rekryterar inte ännu
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
    Verifierat postnummer
    Milano, Italien· Rekryterar inte ännu
  • Azienda Ospedaliero-Universitaria di Modena
    Verifierat postnummer
    Modena, Italy· Rekryterar inte ännu
  • Haukeland universitetssjukhus
    Verifierat postnummer
    Bergen, Norge· Rekryterar inte ännu

Vanliga frågor

Vad är en 'observationsstudie'?

An observational study means researchers watch and collect information about your condition without giving you any new treatments or medicines. They just observe what is already happening.

Kommer jag att få ny medicin i denna studie?

No, this study is about collecting information only. You will not be given any new treatments or medications as part of your participation.

Hur länge behöver jag vara med i studien?

The study will last for up to 6 months for each person who takes part.

Vilka typer av tester kommer jag att ha?

You'll have physical exams, blood tests, your vital signs (like blood pressure) checked, and you'll complete a daily diary. You might also wear a device that measures light.

Kan jag lämna studien om jag ändrar mig?

Yes, you can decide to leave the study at any time, for any reason. It will not affect your usual medical care.

Hur du får reda på mer

GondolaBio Inquiries

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "Observational Study of Adults and Adolescents With Erythropo…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.